SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

This publication has 43 references indexed in Scilit:

• A Risk-Benefit Assessment of Mirtazapine in the Treatment of Depression
  Drug Safety, 1997
• Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression
  The Journal of Clinical Psychiatry, 1997
• Nefazodone
  Drugs, 1997
• Mirtazapine
  CNS Drugs, 1996
• Efficacy of Org 3770 (mirtazapine) vs amitriptyline in patients with major depressive disorder: A meta-analysis
  Human Psychopharmacology: Clinical and Experimental, 1995
• Org 3770 (mirtazapine) versus trazodone: A placebo controlled trial in depressed elderly patients
  Human Psychopharmacology: Clinical and Experimental, 1995
• A double-blind placebo-controlled study of Org 3770 in depressed outpatients
  Journal of Affective Disorders, 1995
• Drug and Ethanol Effects on the Clinical Test for Drunkenness: Single Doses of Ethanol, Hypnotic Drugs and Antidepressant Drugs
  Basic & Clinical Pharmacology & Toxicology, 1994
• Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes
  Life Sciences, 1993
• Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl Metabolite
  The Journal of Clinical Pharmacology, 1992